Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ASPIRIN Cause Atrioventricular block first degree? 53 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 53 reports of Atrioventricular block first degree have been filed in association with ASPIRIN (Aspirin). This represents 0.1% of all adverse event reports for ASPIRIN.

53
Reports of Atrioventricular block first degree with ASPIRIN
0.1%
of all ASPIRIN reports
32
Deaths
48
Hospitalizations

How Dangerous Is Atrioventricular block first degree From ASPIRIN?

Of the 53 reports, 32 (60.4%) resulted in death, 48 (90.6%) required hospitalization, and 16 (30.2%) were considered life-threatening.

Is Atrioventricular block first degree Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ASPIRIN. However, 53 reports have been filed with the FAERS database.

What Other Side Effects Does ASPIRIN Cause?

Gastrointestinal haemorrhage (13,172) Anaemia (4,568) Off label use (4,283) Dyspnoea (4,280) Drug hypersensitivity (4,072) Drug ineffective (4,061) Upper gastrointestinal haemorrhage (3,411) Epistaxis (3,214) Rectal haemorrhage (3,057) Acute kidney injury (2,976)

What Other Drugs Cause Atrioventricular block first degree?

FINGOLIMOD (285) AMLODIPINE (148) METOPROLOL (120) BISOPROLOL (98) FLECAINIDE (98) OMEPRAZOLE (94) AMIODARONE (85) VERAPAMIL (84) DILTIAZEM (79) FUROSEMIDE (78)

Which ASPIRIN Alternatives Have Lower Atrioventricular block first degree Risk?

ASPIRIN vs ASPIRIN DL-LYSINE ASPIRIN vs ASPIRIN LYSINE ASPIRIN vs ASPIRIN\BUTALBITAL\CAFFEINE ASPIRIN vs ASPIRIN\CAFFEINE ASPIRIN vs ASPIRIN\CARISOPRODOL

Related Pages

ASPIRIN Full Profile All Atrioventricular block first degree Reports All Drugs Causing Atrioventricular block first degree ASPIRIN Demographics